Phio Pharmaceuticals Corp. (PHIO) - Kompaniyaning xususiy kapitali

Ommaviy kompaniya RXi Pharmaceuticals (PHIO) logotipi

Phio Pharmaceuticals (PHIO) transport jarayonida harorat nazoratiga qat'iy rioya qilish orqali dori vositalarining barqarorligini ta'minlaydi. Firmaning ekologik izi minimal darajada bo'lib, standart chiqindilarni qayta ishlash bilan cheklangan. RNA yetkazib berish bo'yicha noyob patentlar va FDA ning qat'iy nazorati biznes himoyasini kafolatlaydi, shu bilan birga ko'rsatkich 0.01 darajasida turibdi. Quyidagi bozor narxlari grafigi innovatsion genetik dori vositalarini ishlab chiqadigan kompaniyaning narxlar dinamikasini aks ettiradi.

Phio Pharmaceuticals Corp (PHIO) - Kompaniyaning balans qiymati 04.07.2022dan 28.10.2026gacha

Phio Pharmaceuticals kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Birja grafigi Phio Pharmaceuticals|PHIO - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Phio Pharmaceuticals Corp|PHIO - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Phio Pharmaceuticals|PHIO - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati phiopharma.com|PHIO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Phio Pharmaceuticals|PHIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati Phio Pharmaceuticals|PHIO - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Phio Pharmaceuticals Corp
Kompaniyaning fundamental tahlili:PHIO - Phio Pharmaceuticals Corp.
RXi Pharmaceuticals yetakchi tovari

Barqaror daromad oqimiga ega bo'lmagan RNA terapiyasi ishlab chiquvchisi Phio Pharmaceuticals (PHIO) uchun kitob kapitalizatsiyasi barcha majburiyatlar to'langanidan keyingi qoldiq kapitalning o'lchovi bo'lib xizmat qiladi. Kompaniyaning kitob kapitalizatsiyasi tarixini tahlil qilish orqali investor R&D platformasining sof aktivlar hisobiga operatsiyalarni qo'llab-quvvatlash qobiliyatini baholaydi, bu esa klinik sinovlar bosqichidagi salbiy leveraj va kengaytiriladigan marjalarning yo'qligini hisobga olganda juda muhimdir.

Phio Pharmaceuticals kimlar bilan raqobatlashadi

TEM: Biznesning balans bahosi|Kompaniyaning balans qiymati QGEN|ionispharma.com (IONS) - Kompaniyaning xususiy kapitali|Balans kapitallashuvi Repligen (RGEN)|Buxgalteriya kapitallashuvi RNA|Kompaniyaning balans qiymati CRISPR Therapeutics Corp CRSP|Buxgalteriya kapitallashuvi GeneDx Corp (WGS)|Balans kapitallashuvi RARE (Ultragenyx Pharmaceutical)|beamtx.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Sarepta|TWST - Sof aktivlar qiymati|Balans kapitallashuvi 10x Genomics Corp TXG|Intellia Corp (NTLA) - Kompaniyaning buxgalteriya qiymati|STOK: Balans kapitallashuvi|Biznesning balans bahosi BLFS|Wave Life Sciences Ltd. - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali Maze Therapeutics, Inc. MAZE|Kompaniyaning sof aktivlari Sionna Pharma|Prime Medicine Bio - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Taysha Gene Therapies|QURE - Sof aktivlar qiymati|Balans kapitallashuvi MeiraGTx MGTX|REGENXBIO Inc (RGNX) - Kompaniyaning buxgalteriya qiymati|SLDB (Solid Bio) - Balans kapitallashuvi|Balans kapitallashuvi OCGN|Pacific Biosciences (PACB) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati BNTC (benitec.com)|Design Therapeutics, Inc. - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Rocket Pharma RCKT|4D Molecular Therapeutics Inc - Balans kapitallashuvi|LXEO - Balans kapitallashuvi|KRRO (korrobio.com) - Balans kapitallashuvi|editasmedicine.com (EDIT) - Kompaniyaning sof aktivlari|Balans kapitallashuvi SLN (Silence Therapeutics plc)|Kompaniyaning xususiy kapitali ProQR Therapeutics NV (PRQR)|Kompaniyaning sof aktivlari CDXS|Balans kapitallashuvi Sangamo BioSciences SGMO|Kompaniyaning sof aktivlari Nautilus Bio (NAUT)|Jami sof aktivlar metagenomi.co MGX|Balans kapitallashuvi DTIL (Precision BioSciences)|GBIO - Biznesning balans bahosi|BOLD (Boundless Bio, Inc) - Balans kapitallashuvi|Exicure (XCUR) - Kompaniyaning sof aktivlari|IMNN (Imunon Inc) - Balans kapitallashuvi|Balans kapitallashuvi MBIO|Kompaniyaning balans qiymati TransCode Therapeutics (RNAZ)|Kompaniyaning balans qiymati BNGO (bionanogenomics.com)|Kompaniyaning balans qiymati APDN|bluebird bio, Inc - Biznesning balans bahosi|Kompaniyaning balans qiymati ImmunoPrecise|OMGA - Sof aktivlar qiymati|Balans kapitallashuvi Singular Genomics OMIC|Regulus Therapeutics, Inc. (RGLS) - Kompaniyaning buxgalteriya qiymati|SYRS: Balans kapitallashuvi|Biznesning balans bahosi TBIO|TRACON Pharmaceuticals - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali unitybiotechnology.com (UBX)